{
    "clinical_study": {
        "@rank": "164888", 
        "acronym": "cVATS", 
        "arm_group": [
            {
                "arm_group_label": "segmentectomy", 
                "arm_group_type": "Experimental", 
                "description": "Patients undergo cVATS (complete Video-assisted Thoracoscopic Surgery) segmentectomy"
            }, 
            {
                "arm_group_label": "Lobectomy", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients undergo cVATS lobectomy"
            }
        ], 
        "brief_summary": {
            "textblock": "This is a Prospective, open-label, parallel, multi-center, Phase III randomized trial to\n      evaluate the efficacy and safety of video-assisted thoracoscopic segmentectomy versus\n      Lobectomy in treating patients with Lung adenocarcinoma in situ or with microinvasion."
        }, 
        "brief_title": "Comparison of cVATS Segmentectomy Versus Lobectomy for Lung Adenocarcinoma in Situ and With Microinvasion", 
        "completion_date": {
            "#text": "December 2021", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Non-small Cell Lung Cancer Stage I", 
            "Lung Adenocarcinoma"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Adenocarcinoma", 
                "Carcinoma, Non-Small-Cell Lung", 
                "Lung Neoplasms", 
                "Carcinoma in Situ"
            ]
        }, 
        "detailed_description": {
            "textblock": "Lobectomy has long been considered the standard procedure for early-stage lung cancer, and\n      minimally invasive techniques have been demonstrated to be associated with superior outcomes\n      compared with lobectomy by thoracotomy. the us of segmentectomy is under investigation for\n      selected patients with small tumors, and the use of minimally invasive strategies is\n      applicable as well.\n\n      This nationwide, multicenter, prospective, randomized open phase III study of cVATS\n      (complete Video-assisted Thoracoscopic Surgery) segmentectomy versus Lobectomy for stage IA\n      non-small cell lung cancer (NSCLC) patients with Lung adenocarcinoma in situ or with\n      microinvasion, is aiming to evaluate the relapse free survival and 5 year overall survival\n      (OS) rate of two types of surgery. Patients are randomized to 1 of 2 treatment arms.\n\n        -  Arm I: Patients undergo cVATS lobectomy.\n\n        -  Arm II: Patients undergo cVATS segmentectomy.\n\n      Patients will be followed up every 3 months within the first year, and annually for 5 years\n      postoperatively."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Preoperative criteria: peripheral non-small cell lung cancer, no larger than 2 cm in\n        maximal diameter, no lymph node metastasis, FEV1%>50% (FEV1: Forced Expiratory Volume in 1\n        second);\n\n        Preoperative imaging:pure ground-glass or mixed ground-glass nodules (part-solid, solid\n        areas < 0.5cm);\n\n        Follow-up duration last 3 months or more, HRCT (HRCT: high-resolution computed tomography)\n        lesion maximum diameter was measured three times and took the average, meet the criteria\n        of clinical surgical indications;\n\n        Intraoperative criteria: histologically confirmed NSCLC, adenocarcinoma in situ or with\n        microinvasion;\n\n        No prior ipsilateral thoracotomy;\n\n        No prior anti-neoplastic therapy;\n\n        EOCG Performance status 0-2;\n\n        Sufficient organ functions;\n\n        Written informed consent.\n\n        Exclusion Criteria:\n\n        Active bacterial or fungous infection;\n\n        Simultaneous or prior (within the past 5 years) other malignant disease;\n\n        Interstitial pneumonitis, pulmonary fibrosis, or severe COPD (COPD: chronic obstructive\n        pulmonary disease);\n\n        Abnormal Psychosis;\n\n        Uncontrollable diabetes mellitus;\n\n        History of severe cardiovascular disease;\n\n        Any condition which, in the opinion of the investigator might interfere with the\n        evaluation of the objective."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "79 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "500", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 16, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02011997", 
            "org_study_id": "FAH-GZU-001"
        }, 
        "intervention": [
            {
                "arm_group_label": "segmentectomy", 
                "intervention_name": "patients undergo cVATS segmentectomy", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Lobectomy", 
                "intervention_name": "Patients undergo cVATS lobectomy", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 13, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Guangzhou", 
                        "country": "China", 
                        "state": "Guangdong"
                    }, 
                    "name": "Nanfang Hospital"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Guangzhou", 
                        "country": "China", 
                        "state": "Guangdong", 
                        "zip": "510000"
                    }, 
                    "name": "The First Affiliated Hospital of Guangzhou Medical University"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hangzhou", 
                        "country": "China", 
                        "state": "Zhejiang"
                    }, 
                    "name": "First Affiliated Hospital Zhejiang University colleague of Medicine"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Beijing", 
                        "country": "China"
                    }, 
                    "name": "Peking University Cancer Hospital"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bejing", 
                        "country": "China"
                    }, 
                    "name": "China-Japan Friendship hospital"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Shanghai", 
                        "country": "China"
                    }, 
                    "name": "Shanghai Chest Hospital"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "2", 
        "official_title": "Comparison of Video-assisted Thoracoscopic Segmentectomy Versus Lobectomy for Lung Adenocarcinoma in Situ and With Microinvasion", 
        "overall_contact": {
            "email": "drjianxinghe@163.com", 
            "last_name": "Jianxing He, MD", 
            "phone": "83062810"
        }, 
        "overall_official": {
            "affiliation": "First Affiliated Hospital of Guangzhou Medical University", 
            "last_name": "Jianxing He, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "China: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "December 2021", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Compare the relapse-free survival (RFS) of patients with lung adenocarcinoma in situ or microinvasion undergoing cVATS segmentectomy vs lobectomy.", 
            "measure": "Relapse-free survival", 
            "safety_issue": "No", 
            "time_frame": "From date of randomization until the date of first documented relapse or metastasis, whichever came first, assessed up to 5 years"
        }, 
        "reference": [
            {
                "PMID": "21828029", 
                "citation": "Van Schil PE, Asamura H, Rusch VW, Mitsudomi T, Tsuboi M, Brambilla E, Travis WD. Surgical implications of the new IASLC/ATS/ERS adenocarcinoma classification. Eur Respir J. 2012 Feb;39(2):478-86. doi: 10.1183/09031936.00027511. Epub 2011 Aug 4. Review."
            }, 
            {
                "PMID": "7677489", 
                "citation": "Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg. 1995 Sep;60(3):615-22; discussion 622-3."
            }, 
            {
                "PMID": "19766789", 
                "citation": "Koike T, Togashi K, Shirato T, Sato S, Hirahara H, Sugawara M, Oguma F, Usuda H, Emura I. Limited resection for noninvasive bronchioloalveolar carcinoma diagnosed by intraoperative pathologic examination. Ann Thorac Surg. 2009 Oct;88(4):1106-11. doi: 10.1016/j.athoracsur.2009.06.051."
            }, 
            {
                "PMID": "19289625", 
                "citation": "Yan TD, Black D, Bannon PG, McCaughan BC. Systematic review and meta-analysis of randomized and nonrandomized trials on safety and efficacy of video-assisted thoracic surgery lobectomy for early-stage non-small-cell lung cancer. J Clin Oncol. 2009 May 20;27(15):2553-62. doi: 10.1200/JCO.2008.18.2733. Epub 2009 Mar 16. Review."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02011997"
        }, 
        "responsible_party": {
            "investigator_affiliation": "The First Affiliated Hospital of Guangzhou Medical University", 
            "investigator_full_name": "Jianxing He", 
            "investigator_title": "President", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Compare the 5-year survival rate of patients undergoing cVATS segmentectomy vs lobectomy", 
                "measure": "5-year survival rate", 
                "safety_issue": "No", 
                "time_frame": "participants are followed until death or up to 5 years"
            }, 
            {
                "description": "Compare the postoperative complication rate of patients undergoing cVATS segmentectomy vs lobectomy", 
                "measure": "postoperative complication", 
                "safety_issue": "Yes", 
                "time_frame": "0 to 3 months postoperatively"
            }, 
            {
                "description": "to evaluate the pulmonary function as measured by expiratory flow rate of the two groups 6 months postoperatively", 
                "measure": "pulmonary function", 
                "safety_issue": "No", 
                "time_frame": "6 months after surgery"
            }, 
            {
                "description": "To evaluate the quality of life (QoL) of these patients, as measured by questionnaire of FACT-L (4th edition) and LCSS (Lung Cancer Symptom Scale)", 
                "measure": "Quality of Life", 
                "safety_issue": "No", 
                "time_frame": "0 to 6 months postoperative"
            }
        ], 
        "source": "The First Affiliated Hospital of Guangzhou Medical University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "The First Affiliated Hospital of Guangzhou Medical University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}